Felizardo, Raphael José Ferreira; Almeida, Danilo Candido de 
; Pereira, Rafael Luiz; Watanabe, Ingrid Kazue Mizuno; Doimo, Nayara Trevisan dos Santos; Ribeiro, Willian Rodrigues; Cenedeze, Marcos Antonio; Hiyane, Meire Ioshie; Amano, Mariane Tami ; Braga, Tárcio Teodoro ; Ferreira, Caroline Marcantonio ; Parmigiani, Raphael Bessa; Oliveira, Vinicius de Andrade ; Volpini, Rildo Aparecido ; Vinolo, Marco Aurelio Ramirez ; Moreno, Eliana Mariño ; Robert, Remy ; Mackay, Charles Reay ; Câmara, Niels Olsen Saraiva
Source: The FASEB Journal. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELIZARDO, Raphael José Ferreira et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, v. 33, n. 11, p. 11894-11908, 2019Tradução . . Disponível em: https://doi.org/10.1096/fj.201901080R. Acesso em: 31 ago. 2024.APA
Felizardo, R. J. F., Almeida, D. C. de, Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. dos S., Ribeiro, W. R., et al. (2019). Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms. The FASEB Journal, 33( 11), 11894-11908. doi:10.1096/fj.201901080RNLM
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1096/fj.201901080RVancouver
Felizardo RJF, Almeida DC de, Pereira RL, Watanabe IKM, Doimo NT dos S, Ribeiro WR, Cenedeze MA, Hiyane MI, Amano MT, Braga TT, Ferreira CM, Parmigiani RB, Oliveira V de A, Volpini RA, Vinolo MAR, Moreno EM, Robert R, Mackay CR, Câmara NOS. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms [Internet]. The FASEB Journal. 2019 ; 33( 11): 11894-11908.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1096/fj.201901080R
